EV/Assets Ratio: 3.83x
Is the EV/Assets ratio high or low?
The EV/Assets ratio of 3.83x is 29% below its 5-year average of 5.41x, near the low end of its 5-year range (2.80x–10.02x).
As of Sunday, June 28, 2026. 12.78% above its 12-month average of 3.40x.
EW EV/Assets Ratio Chart
EW Average EV/Assets Ratio Chart
EW Current vs Average EV/Assets Ratio Chart
EW EV/Assets Ratio Metrics
EV/ASSETS RATIO
3.83x
EV/ASSETS RATIO AVG TTM
3.40x
EV/ASSETS RATIO AVG 3Y
4.06x
EV/ASSETS RATIO AVG 5Y
5.41x
EV/ASSETS RATIO AVG 10Y
5.89x
EV/ASSETS RATIO AVG 15Y
5.32x
EV/ASSETS RATIO AVG 20Y
4.75x
CURRENT VS TTM AVG
+12.78%
CURRENT VS 3Y AVG
-5.72%
CURRENT VS 5Y AVG
-29.25%
CURRENT VS 10Y AVG
-34.97%
CURRENT VS 15Y AVG
-28.06%
CURRENT VS 20Y AVG
-19.33%
EW Competitors' EV/Assets Ratio
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation (EW) | $52.27B | 3.83x | 3.40x | 4.06x | 5.41x |
| Cencora, Inc. (COR)vs › | $55.67B | 0.81x | 0.90x | 0.80x | 0.72x |
| Cardinal Health, Inc. (CAH)vs › | $55.72B | 1.08x | 0.92x | 0.73x | 0.62x |
| Becton, Dickinson and Company (BDX)vs › | $56.49B | 1.18x | 1.14x | 1.24x | 1.27x |
| Humana Inc. (HUM)vs › | $46.08B | 1.00x | 0.76x | 0.87x | 1.09x |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.50B | 13.41x | 15.31x | 13.68x | 15.09x |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $65.20B | 1.66x | 1.82x | 2.49x | 2.69x |
| Boston Scientific Corporation (BSX)vs › | $65.74B | 1.71x | 3.24x | 3.29x | 2.87x |
| Agilent Technologies, Inc. (A)vs › | $38.41B | 3.07x | 3.06x | 3.38x | 3.70x |
| Medline Inc. (MDLN)vs › | $32.87B | 1.09x | 1.16x | 1.16x | 1.16x |
EV/Assets Ratio Formula & Definition
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/Assets Ratio FAQ
- What is the EV/Assets ratio for Edwards Lifesciences Corporation (EW)?
- The EV/Assets ratio for EW stock is 3.83x.
- Is Edwards Lifesciences Corporation's EV/Assets ratio high or low?
- The EV/Assets ratio of 3.83x is 29% below its 5-year average of 5.41x, near the low end of its 5-year range (2.80x–10.02x).
- What is the TTM average EV/Assets ratio for Edwards Lifesciences Corporation (EW)?
- The TTM average EV/Assets ratio for EW stock is 3.40x.
- What is the 3Y average EV/Assets ratio for Edwards Lifesciences Corporation (EW)?
- The 3Y average EV/Assets ratio for EW stock is 4.06x.
- What is the 5Y average EV/Assets ratio for Edwards Lifesciences Corporation (EW)?
- The 5Y average EV/Assets ratio for EW stock is 5.41x.
- What is the 10Y average EV/Assets ratio for Edwards Lifesciences Corporation (EW)?
- The 10Y average EV/Assets ratio for EW stock is 5.89x.
- What is the 15Y average EV/Assets ratio for Edwards Lifesciences Corporation (EW)?
- The 15Y average EV/Assets ratio for EW stock is 5.32x.
- What is the 20Y average EV/Assets ratio for Edwards Lifesciences Corporation (EW)?
- The 20Y average EV/Assets ratio for EW stock is 4.75x.
EW EV/Assets Ratio History
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-06-26 | 3.83x |
| 2026-06-25 | 3.78x |
| 2026-06-24 | 3.78x |
| 2026-06-23 | 3.66x |
| 2026-06-22 | 3.61x |
| 2026-06-18 | 3.68x |
| 2026-06-17 | 3.65x |
| 2026-06-16 | 3.73x |
| 2026-06-15 | 3.63x |
| 2026-06-12 | 3.58x |
| 2026-06-11 | 3.61x |
| 2026-06-10 | 3.62x |
| 2026-06-09 | 3.69x |
| 2026-06-08 | 3.61x |
| 2026-06-05 | 3.62x |
| 2026-06-04 | 3.68x |
| 2026-06-03 | 3.62x |
| 2026-06-02 | 3.69x |
| 2026-06-01 | 3.71x |
| 2026-05-29 | 3.64x |
| 2026-05-28 | 3.62x |
| 2026-05-27 | 3.64x |
| 2026-05-26 | 3.69x |
| 2026-05-22 | 3.61x |
| 2026-05-21 | 3.50x |
| 2026-05-20 | 3.49x |
| 2026-05-19 | 3.45x |
| 2026-05-18 | 3.46x |
| 2026-05-15 | 3.42x |
| 2026-05-14 | 3.41x |
| 2026-05-13 | 3.42x |
| 2026-05-12 | 3.34x |
| 2026-05-11 | 3.23x |
| 2026-05-08 | 3.35x |
| 2026-05-07 | 3.48x |
| 2026-05-06 | 3.50x |
| 2026-05-05 | 3.36x |
| 2026-05-04 | 3.38x |
| 2026-05-01 | 3.40x |
| 2026-04-30 | 3.38x |
| 2026-04-29 | 3.29x |
| 2026-04-28 | 3.33x |
| 2026-04-27 | 3.38x |
| 2026-04-24 | 3.41x |
| 2026-04-23 | 3.22x |
| 2026-04-22 | 3.30x |
| 2026-04-21 | 3.22x |
| 2026-04-20 | 3.30x |
| 2026-04-17 | 3.28x |
| 2026-04-16 | 3.19x |
| 2026-04-15 | 3.16x |
| 2026-04-14 | 3.16x |
| 2026-04-13 | 3.16x |
| 2026-04-10 | 3.14x |
| 2026-04-09 | 3.20x |
| 2026-04-08 | 3.31x |
| 2026-04-07 | 3.27x |
| 2026-04-06 | 3.29x |
| 2026-04-02 | 3.28x |
| 2026-04-01 | 3.29x |
| 2026-03-31 | 3.24x |
| 2026-03-30 | 3.21x |
| 2026-03-27 | 3.21x |
| 2026-03-26 | 3.32x |
| 2026-03-25 | 3.35x |
| 2026-03-24 | 3.31x |
| 2026-03-23 | 3.32x |
| 2026-03-20 | 3.34x |
| 2026-03-19 | 3.34x |
| 2026-03-18 | 3.35x |
| 2026-03-17 | 3.42x |
| 2026-03-16 | 3.39x |
| 2026-03-13 | 3.31x |
| 2026-03-12 | 3.43x |
| 2026-03-11 | 3.45x |
| 2026-03-10 | 3.48x |
| 2026-03-09 | 3.42x |
| 2026-03-06 | 3.30x |
| 2026-03-05 | 3.40x |
| 2026-03-04 | 3.46x |
| 2026-03-03 | 3.46x |
| 2026-03-02 | 3.54x |
| 2026-02-27 | 3.51x |
| 2026-02-26 | 3.49x |
| 2026-02-25 | 3.38x |
| 2026-02-24 | 3.49x |
| 2026-02-23 | 3.49x |
| 2026-02-20 | 3.37x |
| 2026-02-19 | 3.33x |
| 2026-02-18 | 3.34x |
| 2026-02-17 | 3.31x |
| 2026-02-13 | 3.20x |
| 2026-02-12 | 3.22x |
| 2026-02-11 | 3.35x |
| 2026-02-10 | 3.25x |
| 2026-02-09 | 3.24x |
| 2026-02-06 | 3.32x |
| 2026-02-05 | 3.30x |
| 2026-02-04 | 3.37x |
| 2026-02-03 | 3.47x |
| 2026-02-02 | 3.50x |
| 2026-01-30 | 3.44x |
| 2026-01-29 | 3.45x |
| 2026-01-28 | 3.46x |
| 2026-01-27 | 3.54x |
| 2026-01-26 | 3.57x |
| 2026-01-23 | 3.54x |
| 2026-01-22 | 3.58x |
| 2026-01-21 | 3.61x |
| 2026-01-20 | 3.53x |
| 2026-01-16 | 3.57x |
| 2026-01-15 | 3.58x |
| 2026-01-14 | 3.52x |
| 2026-01-13 | 3.55x |
| 2026-01-12 | 3.51x |
| 2026-01-09 | 3.61x |
| 2026-01-08 | 3.58x |
| 2026-01-07 | 3.59x |
| 2026-01-06 | 3.64x |
| 2026-01-05 | 3.56x |
| 2026-01-02 | 3.62x |
| 2025-12-31 | 3.61x |
| 2025-12-30 | 3.65x |
| 2025-12-29 | 3.69x |
| 2025-12-26 | 3.68x |
| 2025-12-24 | 3.66x |
| 2025-12-23 | 3.66x |
| 2025-12-22 | 3.67x |
| 2025-12-19 | 3.63x |
| 2025-12-18 | 3.59x |
| 2025-12-17 | 3.59x |
| 2025-12-16 | 3.62x |
| 2025-12-15 | 3.53x |
| 2025-12-12 | 3.52x |
| 2025-12-11 | 3.57x |
| 2025-12-10 | 3.55x |
| 2025-12-09 | 3.53x |
| 2025-12-08 | 3.57x |
| 2025-12-05 | 3.65x |
| 2025-12-04 | 3.64x |
| 2025-12-03 | 3.56x |
| 2025-12-02 | 3.59x |
| 2025-12-01 | 3.61x |
| 2025-11-28 | 3.68x |
| 2025-11-26 | 3.68x |
| 2025-11-25 | 3.68x |
| 2025-11-24 | 3.59x |
| 2025-11-21 | 3.61x |
| 2025-11-20 | 3.56x |
| 2025-11-19 | 3.65x |
| 2025-11-18 | 3.56x |
| 2025-11-17 | 3.59x |
| 2025-11-14 | 3.66x |
| 2025-11-13 | 3.65x |
| 2025-11-12 | 3.63x |
| 2025-11-11 | 3.61x |
| 2025-11-10 | 3.56x |
| 2025-11-07 | 3.53x |
| 2025-11-06 | 3.49x |
| 2025-11-05 | 3.51x |
| 2025-11-04 | 3.48x |
| 2025-11-03 | 3.43x |
| 2025-10-31 | 3.40x |
| 2025-10-30 | 3.45x |
| 2025-10-29 | 3.41x |
| 2025-10-28 | 3.39x |
| 2025-10-27 | 3.33x |
| 2025-10-24 | 3.13x |
| 2025-10-23 | 3.14x |
| 2025-10-22 | 3.16x |
| 2025-10-21 | 3.12x |
| 2025-10-20 | 3.09x |
| 2025-10-17 | 3.06x |
| 2025-10-16 | 2.98x |
| 2025-10-15 | 2.99x |
| 2025-10-14 | 3.01x |
| 2025-10-13 | 2.99x |
| 2025-10-10 | 3.03x |
| 2025-10-09 | 3.09x |
| 2025-10-08 | 3.11x |
| 2025-10-07 | 3.15x |
| 2025-10-06 | 3.15x |
| 2025-10-03 | 3.17x |
| 2025-10-02 | 3.15x |
| 2025-10-01 | 3.14x |
| 2025-09-30 | 3.20x |
| 2025-09-29 | 3.17x |
| 2025-09-26 | 3.13x |
| 2025-09-25 | 3.09x |
| 2025-09-24 | 3.06x |
| 2025-09-23 | 3.06x |
| 2025-09-22 | 3.02x |
| 2025-09-19 | 3.05x |
| 2025-09-18 | 3.06x |
| 2025-09-17 | 3.09x |
| 2025-09-16 | 3.08x |
| 2025-09-15 | 3.12x |
| 2025-09-12 | 3.19x |
| 2025-09-11 | 3.21x |
| 2025-09-10 | 3.22x |
| 2025-09-09 | 3.29x |
| 2025-09-08 | 3.31x |
| 2025-09-05 | 3.34x |
| 2025-09-04 | 3.34x |
| 2025-09-03 | 3.35x |
| 2025-09-02 | 3.37x |
| 2025-08-29 | 3.35x |
| 2025-08-28 | 3.35x |
| 2025-08-27 | 3.34x |
| 2025-08-26 | 3.35x |
| 2025-08-25 | 3.33x |
| 2025-08-22 | 3.38x |
| 2025-08-21 | 3.35x |
| 2025-08-20 | 3.36x |
| 2025-08-19 | 3.25x |
| 2025-08-18 | 3.22x |
| 2025-08-15 | 3.22x |
| 2025-08-14 | 3.22x |
| 2025-08-13 | 3.20x |
| 2025-08-12 | 3.16x |
| 2025-08-11 | 3.22x |
| 2025-08-08 | 3.22x |
| 2025-08-07 | 3.21x |
| 2025-08-06 | 3.24x |
| 2025-08-05 | 3.39x |
| 2025-08-04 | 3.43x |
| 2025-08-01 | 3.39x |
| 2025-07-31 | 3.39x |
| 2025-07-30 | 3.48x |
| 2025-07-29 | 3.44x |
| 2025-07-28 | 3.36x |
| 2025-07-25 | 3.42x |
| 2025-07-24 | 3.23x |
| 2025-07-23 | 3.28x |
| 2025-07-22 | 3.26x |
| 2025-07-21 | 3.27x |
| 2025-07-18 | 3.27x |
| 2025-07-17 | 3.25x |
| 2025-07-16 | 3.25x |
| 2025-07-15 | 3.28x |
| 2025-07-14 | 3.35x |
| 2025-07-11 | 3.34x |
| 2025-07-10 | 3.37x |
| 2025-07-09 | 3.30x |
| 2025-07-08 | 3.26x |
| 2025-07-07 | 3.27x |
| 2025-07-03 | 3.28x |
| 2025-07-02 | 3.29x |
| 2025-07-01 | 3.30x |
| 2025-06-30 | 3.34x |
| 2025-06-27 | 3.34x |
| 2025-06-26 | 3.29x |
| 2025-06-25 | 3.29x |
| 2025-06-24 | 3.24x |
| 2025-06-23 | 3.21x |
| 2025-06-20 | 3.15x |
| 2025-06-18 | 3.15x |
| 2025-06-17 | 3.12x |
| 2025-06-16 | 3.19x |
| 2025-06-13 | 3.20x |
Showing the most recent 260 of 5,032 data points. The chart above shows the full history.
Related Metrics
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Bernard J. Zovighian